Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 5, 2020
The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivorsNele Stadtbaeumer, Horst Müller, Helen Goergen, et al.Hemasphere|November 15, 2019
Suicide in European Hodgkin Lymphoma PatientsAustin I Kim, Helen Goergen, Andreas Engert, et al.Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.International Journal of Radiation Oncology, Biology, Physics|August 14, 2021
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 TrialChristian Baues, Helen Goergen, Michael Fuchs, et al.British Journal of Haematology|January 24, 2021
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Horst Müller, Leonard Elger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2019
Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin LymphomaSven Borchmann, Melita Cirillo, Helen Goergen, et al.Blood|September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphomaCarsten Kobe, Helen Goergen, Christian Baues, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2017
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 TrialsStephanie Sasse, Paul J Bröckelmann, Helen Goergen, et al.Leukemia & Lymphoma|February 14, 2013
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphomaStephanie Sasse, Achim Rothe, Helen Goergen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 TrialsPaul J Bröckelmann, Helen Goergen, Charlotte Kohnhorst, et al.Pageof 3